Literature DB >> 9558105

Effect of antigen-processing efficiency on in vivo T cell response magnitudes.

S Vijh1, I M Pilip, E G Pamer.   

Abstract

T lymphocytes eradicate and provide long-term immunity to infections caused by intracellular pathogens. The mechanisms that determine in vivo T cell response sizes are poorly understood. Although it is speculated that the relative processing efficiency of different epitopes determines the hierarchy of T cell responses following immunization, this hypothesis has not been rigorously tested. We therefore mutagenized the secreted p60 Ag of Listeria monocytogenes to alter the efficiency of T cell epitope generation. Ag-processing efficiencies in cells infected with the different L. monocytogenes mutants ranged from one H2-Kd-associated p60 217-225 epitope generated per 15 intracellularly degraded p60 molecules (1/15) to one epitope per 350 degraded p60 molecules (1/350), i.e., a spectrum encompassing a 20-fold range of efficiencies. Mice infected with L. monocytogenes secreting inefficiently processed p60 (1/350) did not mount p60 217-225-specific T cell responses. However, increasing the efficiency of Ag processing by a factor of 5 to 1/70 restored the T cell response size to normal, while further increases in the efficiency of p60 217-225 generation to 1/50, 1/35, and 1/17 did not further augment specific T cell responses. Our studies demonstrate an Ag-processing threshold for in vivo T cell activation. Surprisingly, once this threshold is achieved, further enhancement of Ag-processing efficiency does not enhance the size of T cell responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558105

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Immune response and virus population composition: HIV as a case study.

Authors:  Gal Almogy; Netta Cohen; Sabine Stöcker; Lewi Stone
Journal:  Proc Biol Sci       Date:  2002-04-22       Impact factor: 5.349

2.  Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen.

Authors:  Claudia Rollenhagen; Meike Sörensen; Konstantin Rizos; Robert Hurvitz; Dirk Bumann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-01       Impact factor: 11.205

3.  Cross-recognition of N-formylmethionine peptides is a general characteristic of H2-M3-restricted CD8+ T cells.

Authors:  Alexander Ploss; An Tran; Ewa Menet; Ingrid Leiner; Eric G Pamer
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

Review 4.  Re-examining class-I presentation and the DRiP hypothesis.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Jeff D Colbert; Alfred L Goldberg
Journal:  Trends Immunol       Date:  2014-02-21       Impact factor: 16.687

Review 5.  MHC class I restricted T cell responses to Listeria monocytogenes, an intracellular bacterial pathogen.

Authors:  A Finelli; K M Kerksiek; S E Allen; N Marshall; R Mercado; I Pilip; D H Busch; E G Pamer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  Gamma interferon and perforin control the strength, but not the hierarchy, of immunodominance of an antiviral CD8+ T cell response.

Authors:  Sanda Remakus; Luis J Sigal
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

7.  Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction.

Authors:  Douglas C Palmer; Sanjeeve Balasubramaniam; Ken-Ichi Hanada; Claudia Wrzesinski; Zhiya Yu; Shahram Farid; Marc R Theoret; Leroy N Hwang; Christopher A Klebanoff; Luca Gattinoni; Allan L Goldstein; James C Yang; Nicholas P Restifo
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

8.  A reduced antigen load in vivo, rather than weak inflammation, causes a substantial delay in CD8+ T cell priming against Mycobacterium bovis (bacillus Calmette-Guérin).

Authors:  Marsha S Russell; Monica Iskandar; Oksana L Mykytczuk; John H E Nash; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

9.  Selectively reduced intracellular proliferation of Salmonella enterica serovar typhimurium within APCs limits antigen presentation and development of a rapid CD8 T cell response.

Authors:  Homam Albaghdadi; Nirmal Robinson; Brett Finlay; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

10.  Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects.

Authors:  Maria Grazia Ruocco; Karsten A Pilones; Noriko Kawashima; Michael Cammer; Julie Huang; James S Babb; Mengling Liu; Silvia C Formenti; Michael L Dustin; Sandra Demaria
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.